Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
2023年 11月 07日
Read MoreZai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7, 2023
2023年 10月 18日
Read MoreZai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injection) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in China
2023年 9月 18日
Read MoreZai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patients with NTRK-positive TKI-pretreated advanced solid tumors in China
2023年 8月 30日
Read MoreZai Lab Announces Second Quarter 2023 Financial Results and Corporate Updates
2023年 8月 07日
Read MoreZai Lab to Announce Second Quarter 2023 Financial Results and Corporate Updates on August 7, 2023
2023年 7月 20日
Read More